Crossmark

Immunization with recombinant fusion of LTB and linear epitope (40–62) of epsilon toxin elicits protective immune response against the epsilon toxin of Clostridium perfringens type D

Crossref DOI link: https://doi.org/10.1186/s13568-019-0824-3

Published Online: 2019-07-12

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kaushik, Himani

Deshmukh, Sachin Kumar

Solanki, Amit Kumar

Bhatia, Bharti

Tiwari, Archana

Garg, Lalit C. https://orcid.org/0000-0001-6640-5383
Funding

Funding for this research was provided by:

Life Sciences Rsearch Board, Defence Research and Development Organization, New Delhi (DLS/81/48222/LSRB-178/SH&DD/2008)
License Information

Text and Data Mining valid from 2019-07-12

Version of Record valid from 2019-07-12
More Information

Article History

Received: 28 February 2019

Accepted: 26 June 2019

First Online: 12 July 2019

Ethics approval and consent to participate

: This article does not contain any studies with human participants performed by any of the authors. Animal usage for the study was approved by the Institutional Animal Ethics Committee, National Institute of Immunology, New Delhi. All applicable international, national and institutional guidelines for the care and use of the animals were followed.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below